{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:55:56Z","timestamp":1773302156054,"version":"3.50.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227350","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T13:32:29Z","timestamp":1578663149000},"page":"e0227350","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-2889","authenticated-orcid":true,"given":"Apostolos A.","family":"Alexandridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4098-605X","authenticated-orcid":true,"given":"Nabarun","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Ringwalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne D.","family":"Rosamond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Chelminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2664-9233","authenticated-orcid":true,"given":"Stephen W.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"issue":"11","key":"pone.0227350.ref001","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2105\/AJPH.2014.302147","article-title":"Moving Beyond Misuse and Diversion: The Urgent Need to Consider the Role of Iatrogenic Addiction in the Current Opioid Epidemic","volume":"104","author":"GA Beauchamp","year":"2014","journal-title":"American journal of public health"},{"issue":"1","key":"pone.0227350.ref002","article-title":"Long-term opioid management for chronic noncancer pain","author":"M Noble","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"pone.0227350.ref003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.JAA.0000464268.60257.ad","article-title":"The evolution of chronic opioid therapy and recognizing addiction","volume":"28","author":"AM Daum","year":"2015","journal-title":"Journal of the American Academy of Physician Assistants"},{"issue":"4","key":"pone.0227350.ref004","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/pmt.13.24","article-title":"Opioid maintenance, weaning and detoxification techniques: where we have been, where we are now and what the future holds","volume":"3","author":"A Plunkett","year":"2013","journal-title":"Pain management"},{"issue":"4","key":"pone.0227350.ref005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/AJP.0b013e318298ddad","article-title":"Sublingual Buprenorphine for Chronic Pain: A Survey of Clinician Prescribing Practices","volume":"30","author":"K Rosen","year":"2014","journal-title":"The Clinical Journal of Pain"},{"key":"pone.0227350.ref006","first-page":"1","article-title":"Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic","author":"JR James","year":"2018","journal-title":"Substance abuse"},{"issue":"6","key":"pone.0227350.ref007","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","article-title":"Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment","volume":"54","author":"RL Haffajee","year":"2018","journal-title":"American Journal of Preventive Medicine"},{"issue":"6","key":"pone.0227350.ref008","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.amepre.2018.02.006","article-title":"Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine","volume":"54","author":"CHA Andrilla","year":"2018","journal-title":"American Journal of Preventive Medicine"},{"issue":"4","key":"pone.0227350.ref009","doi-asserted-by":"crossref","first-page":"644","DOI":"10.15288\/jsad.2015.76.644","article-title":"The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis","volume":"76","author":"HK Knudsen","year":"2015","journal-title":"J Stud Alcohol Drugs"},{"issue":"6","key":"pone.0227350.ref010","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1377\/hlthaff.2014.1205","article-title":"Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002\u201311","volume":"34","author":"AW Dick","year":"2015","journal-title":"Health Affairs"},{"issue":"1","key":"pone.0227350.ref011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder","volume":"13","author":"RA Rosenblatt","year":"2015","journal-title":"The Annals of Family Medicine"},{"issue":"11","key":"pone.0227350.ref012","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviours and associated health outcomes in France, 1996\u20132003","volume":"100","author":"J Emmanuelli","year":"2005","journal-title":"Addiction"},{"key":"pone.0227350.ref013","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"RP Mattick","year":"2014","journal-title":"The cochrane library"},{"issue":"4","key":"pone.0227350.ref014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/ADM.0b013e3182312983","article-title":"Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"ML Kraus","year":"2011","journal-title":"J Addict Med"},{"issue":"10","key":"pone.0227350.ref015","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"L Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"pone.0227350.ref016","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","article-title":"The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review","volume":"174","author":"KM Carroll","year":"2017","journal-title":"American Journal of Psychiatry"},{"key":"pone.0227350.ref017","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences, Engineering, Medicine","year":"2019"},{"issue":"2","key":"pone.0227350.ref018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/10826084.2017.1310247","article-title":"\u201cI Was Not Sick and I Didn't Need to Recover\u201d: Methadone Maintenance Treatment (MMT) as a Refuge from Criminalization","volume":"53","author":"D. Frank","year":"2018","journal-title":"Substance Use & Misuse"},{"key":"pone.0227350.ref019","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2017.10.002","article-title":"Prescribing patterns of buprenorphine waivered physicians","volume":"181","author":"CP Thomas","year":"2017","journal-title":"Drug and alcohol dependence"},{"key":"pone.0227350.ref020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugalcdep.2018.02.019","article-title":"Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: Using the prescription behavior surveillance system","volume":"187","author":"Y Zhu","year":"2018","journal-title":"Drug and alcohol dependence"},{"key":"pone.0227350.ref021","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/injuryprev-2017-042396","article-title":"A statewide evaluation of seven strategies to reduce opioid overdose in North Carolina","volume":"24","author":"AA Alexandridis","year":"2018","journal-title":"Injury Prevention"},{"issue":"1","key":"pone.0227350.ref022","first-page":"85","article-title":"Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality","volume":"17","author":"N Dasgupta","year":"2016","journal-title":"Pain Med"},{"key":"pone.0227350.ref023","unstructured":"Centers for Disease Control and Prevention, U. S. Department of Health and Human Services. Calculating total daily dose of opioids for safer dosage. Available from: https:\/\/www.cdc.gov\/drugoverdose\/pdf\/calculating_total_daily_dose-a.pdf."},{"key":"pone.0227350.ref024","first-page":"65","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain\u2014United States, 2016","author":"Centers for Disease Control and Prevention","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"pone.0227350.ref025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/pds.4366","article-title":"Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review","volume":"27","author":"DT Coyle","year":"2018","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"pone.0227350.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain\u2014United States, 2016","volume":"65","author":"D Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"Jan 12","key":"pone.0227350.ref027","first-page":"1","article-title":"How people obtain the prescription pain relievers they misuse","author":"RN Lipari","year":"2017","journal-title":"CBHSQ report"},{"issue":"8","key":"pone.0227350.ref028","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/01.ajp.0000435447.96642.f4","article-title":"What do patients do with unused opioid medications?","volume":"30","author":"ET Lewis","year":"2014","journal-title":"Clin J Pain"},{"issue":"6","key":"pone.0227350.ref029","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/00952990.2015.1043435","article-title":"Dynamic model of nonmedical opioid use trajectories and potential policy interventions","volume":"41","author":"W Wakeland","year":"2015","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"pone.0227350.ref030","article-title":"The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis","author":"D. Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"3","key":"pone.0227350.ref031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.18043\/ncm.79.3.157","article-title":"The Opioid Epidemic in NC: Progress, Challenges, and Opportunities","volume":"79","author":"SM Kansagra","year":"2018","journal-title":"North Carolina Medical Journal"},{"key":"pone.0227350.ref032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugpo.2019.06.019","article-title":"\u201cThey're making it so hard for people to get help:\u201d Motivations for non-prescribed buprenorphine use in a time of treatment expansion","volume":"71","author":"K McLean","year":"2019","journal-title":"International Journal of Drug Policy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T13:32:47Z","timestamp":1578663167000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227350"}},"subtitle":[],"editor":[{"given":"Lars-Peter","family":"Kamolz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227350","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}